Addiction Treatment: Titan Implant to Treat Opioid Addiction Wins Panel Backing – Businessweek

Titan Implant to Treat Opioid Addiction Wins Panel Backing – Businessweek
Filed under: Addiction Treatment

Titan Implant to Treat Opioid Addiction Wins Panel Backing
Businessweek
Titan Pharmaceuticals Inc. (TTNP) won the backing of U.S. regulatory advisers for its experimental implant to treat addiction to heroin and prescription painkillers. Titan's clinical trial data on Probuphine support approval of the matchstick-size
Titan Pharmaceuticals Announces FDA Advisory Committee Recommends MarketWatch (press release)
FDA advisers recommend approval of Titan Pharma's opioid dependence drugReuters

all 3 news articles »

Addiction Treatment – Google News

 

Find More Addiction Treatment Information…